The Cancer Center at Sanford-Burnham Medical Research Institute has been recognized as “outstanding” by the National Cancer Institute (NCI) and has had its NCI-designation renewed for five years. The Institute has been an NCI-designated basic research Cancer Center continuously since 1981, and is only one of seven such Centers in the nation.
This most recent designation also comes with a five-year core grant renewal, which provides more than $21 million to support advanced cancer research at Sanford-Burnham, an amazing 21 percent increase over the previous grant.
With world-class drug discovery capabilities at Sanford-Burnham’s Conrad Prebys Center for Chemical Genomics and more than 400 scientists dedicated to cancer research, Sanford-Burnham is working to translate significant basic research findings into prototype treatments and diagnostics. The Cancer Center also leverages findings from the Institute’s research in inflammation, neurobiology, metabolic diseases and stem cell biology to enhance our understanding of how cancer develops, grows and spreads.
SOURCE: Press release